[About Snake bites in children at the Fez University Hospital (Morocco)]

Jean-Philippe Chippaux1

  • 1UMR 216, Institut de recherche pour le développement, 089 BP 841, Cotonou, Benin.

Insights

Early administration of specific antivenoms is crucial for treating snakebites in North Africa and the Middle East. New generation antivenoms are well-tolerated, especially in children and pregnant women, improving clinical outcomes.

Area of Science:

  • Toxicology
  • Immunology
  • Pharmacology

Background:

  • Snakebite envenomation remains a significant public health concern in North Africa and the Middle East.
  • The effectiveness of immunotherapy relies heavily on the specificity of the antivenom used.
  • Identifying appropriate antivenoms for regional snake species is critical for successful treatment.

Discussion:

  • This review highlights the importance of precise immunotherapy for snakebite victims.
  • Two specific antivenoms are identified as suitable for treating snakebites across North Africa and the Middle East, with a particular focus on Morocco.
  • The discussion emphasizes the need for timely intervention to prevent adverse clinical progression.

Key Insights:

  • Specificity of antivenom is paramount for effective immunotherapy against snakebites.
  • Two key antivenoms are recommended for North Africa, the Middle East, and Morocco.
  • Early and systematic administration of new-generation antivenoms is advised due to their favorable safety profile.

Outlook:

  • Further research into regional snake venom composition and antivenom efficacy is warranted.
  • Improved accessibility and timely administration of appropriate antivenoms can significantly reduce snakebite morbidity and mortality.
  • Special attention should be given to vulnerable populations, including children and pregnant women, in snakebite management protocols.